What Separates a High-Enrolling Site from an Average One? (It's Not What You Think)

The Variables That Don't Predict Enrollment as Well as You'd Think

Patient Volume

A site seeing 500 patients a month with a relevant diagnosis sounds like an enrollment engine. In practice, patient volume predicts screening opportunity, not enrollment rate. A site with 500 monthly patients and a complex scheduling process or a poorly understood protocol may enroll two patients per month. A site with 80 monthly patients, a dedicated research coordinator, and a streamlined pre-screening process may enroll six.

Volume creates potential. Operations convert potential into enrollments.

Institutional Prestige

Academic medical centers bring genuine strengths: subspecialty expertise, access to complex patient populations, regulatory experience. They also bring structural challenges that are routinely underestimated: high coordinator turnover, competing studies that fragment attention, IRB processes that move slowly, and physician investigators whose clinical schedules limit their research availability.

Community sites and private practices often outperform academic centers on a per-patient-seen basis precisely because the operational environment is simpler, the coordinator is dedicated rather than shared, and the investigator has chosen to make research a primary activity rather than a secondary one.

Prior Relationship With the Sponsor

Returning to familiar sites feels like risk reduction. Sometimes it is. But a site that performed well on a different protocol in a different therapeutic area two years ago, under a different coordinator, is not the same site. What the relationship actually provides is familiarity with your processes, which is valuable, but not a substitute for current operational capacity.

What Actually Predicts High Enrollment

1. Coordinator Engagement and Experience

The research coordinator is the operational center of a clinical trial site. Every referral that becomes a screened patient, every screened patient that becomes an enrolled patient, every enrolled patient that completes the study- the coordinator touches all of it. Their engagement level, their experience with the protocol, their availability, and their proactiveness in identifying and contacting eligible patients are the single most predictive factor in site enrollment performance.

High-enrolling sites have coordinators who:

• Proactively review their patient panels for potential eligibility rather than waiting for physician referrals

• Respond to centralized referrals within 24–48 hours rather than days

• Follow up consistently with patients who expressed interest but haven't scheduled

• Communicate quickly when they're seeing unexpected screen failures or operational issues

Low-enrolling sites frequently have coordinators who are managing too many simultaneous studies, are new to the protocol, or are spending a significant portion of their time on administrative tasks that aren't directly connected to patient contact.

When a site that was projecting well suddenly stops enrolling, the first question to ask is: what changed with the coordinator?

2. Pre-Screening Rigor

High-enrolling sites don't waste screening visits on patients who are clearly ineligible. They have a structured pre-screening process that filters out obvious non-qualifiers before the formal screening visit is scheduled.

This matters for two reasons. First, it protects coordinator time and reduces the frustration that leads to coordinator disengagement. Second, it improves the site's screen failure rate, which directly affects their effective enrollment capacity.

Sites that pre-screen rigorously consistently show lower screen failure rates and higher referral-to-enrollment conversion than sites that apply eligibility criteria for the first time at the formal screening visit.

3. Scheduling Speed and Flexibility

The time between a patient expressing interest and their first screening visit is a risk window. Every day in that window is an opportunity for the patient to change their mind, have a competing commitment, or simply forget.

High-enrolling sites schedule screening visits within a week of first contact. They offer flexible scheduling, including early morning, evening, and Saturday options where possible. They confirm appointments proactively and have a follow-up process for no-shows that doesn't simply write off the patient.

Sites with rigid scheduling processes (limited hours, long waits for available appointments, no confirmation workflow) show consistently lower conversion rates even when patient interest is high.

4. Principal Investigator Investment

The degree to which the principal investigator is personally engaged in the study beyond signing off on regulatory documents has a measurable effect on site performance.

PIs who attend coordinator meetings, discuss the protocol with their clinical colleagues, actively refer their own patients to the research team, and engage directly with complex eligibility questions create an environment where research is a priority. PIs who delegate entirely and appear primarily at monitoring visits create an environment where research is an add-on.

This doesn't mean PIs need to be operationally involved in day-to-day recruitment. It means their visible commitment to the study shapes the coordinator's prioritization and the institution's investment in making it work.

5. Local Outreach Infrastructure

The best sites don't only enroll the patients who walk through their doors. They have outreach processes that extend their reach into the surrounding community: relationships with primary care physicians who send referrals, presence in patient support groups, connections with advocacy organizations, and sometimes their own digital presence for study promotion.

This local outreach infrastructure compounds over time. Sites that have been doing research for years have built referral relationships that generate patients for new studies without starting from zero. Sites newer to research, even those with large patient volumes, don't have those pipelines yet.

6. Openness to Centralized Referrals

High-enrolling sites actively participate in centralized recruitment programs. They respond quickly to referrals, provide prompt feedback on why patients were or weren't scheduled, and communicate openly about their capacity to absorb additional referrals.

Sites that treat centralized referrals as a disruption to their workflow, or that consistently fail to follow up on them, effectively have a smaller patient pipeline than their theoretical capacity suggests.

The willingness to work within a centralized recruitment system is both a performance indicator and a signal about the site's overall operational maturity.

Implications for Site Selection

If these are the real predictors of enrollment performance, site selection criteria should reflect them. In practice, this means:

Asking different questions during feasibility. Rather than (or in addition to) asking "how many eligible patients do you see per month?", ask: How many research coordinators do you have, and how many studies are they currently managing? What is your typical time from referral to screening visit? What is your process for pre-screening patients before a formal visit? Have you participated in centralized recruitment programs before?

Requesting historical performance data. Prior enrollment rates on similar protocols, not just prior participation, are more informative than patient volume estimates. A site that enrolled at 80% of projection on a prior study is a better bet than one that projected highly and delivered 40%, regardless of how large their patient population is.

Weighting operational factors alongside clinical ones. The clinical qualifications of the investigator and the depth of the patient population matter. But so does coordinator stability, scheduling flexibility, and local outreach capacity. Both dimensions should be part of the selection decision.

Considering community sites alongside academic centers. For studies where subspecialty expertise isn't a requirement, well-run community sites often outperform academic centers on enrollment efficiency. They should be evaluated systematically, not defaulted away from.

Implications for Site Support

Even the best sites perform better with the right support. High-performing sponsors don't just select good sites- they invest in making sites better.

The specific investments that move the needle:

Pre-screening tools. Providing sites with digital pre-screeners that handle initial eligibility questions removes administrative burden from coordinators and improves the quality of patients entering formal screening.

Rapid-response recruitment support. Sites that have a direct line to a recruitment team- someone they can call when referrals are slow or when they're seeing unexpected screen failure patterns- perform better than sites that manage recruitment entirely in isolation.

Regular performance reviews with actionable data. Sharing enrollment rate vs. projection, screen failure breakdown by criterion, and referral conversion rate with sites gives coordinators and PIs the information they need to self-correct.

Protocol resources that reduce coordinator burden. Clear eligibility cheat sheets, screening visit prep guides, and frequently asked question documents reduce the time coordinators spend on protocol interpretation and increase the time they spend on patient contact.

Key Takeaways

• Patient volume and institutional prestige are weaker predictors of enrollment performance than most sponsors assume.

• The real predictors are coordinator engagement, pre-screening rigor, scheduling speed, PI investment, local outreach infrastructure, and openness to centralized referrals.

• Site selection criteria should explicitly include operational factors alongside clinical ones.

• Historical enrollment performance data is more predictive than patient volume estimates.

• Even strong sites perform better with targeted support: pre-screening tools, rapid-response recruitment backup, and actionable performance data.